Amarin Corp Plc (AMRN)

[BioChica]

Your probably over thinking this and in the past have missed the boat. The marketeers seem to think this stock may reach levels of 10-20 looking at call options in January. So maybe some investors have a good idea EMA approval will come in around these dates. The Vascepa market is large and does not matter who's paying for it either the government or coinsurance. Individuals in the EU do have insurance coverage that fills the gap, that the government does not pay. I came back in at the low point tough to lose money ~3.80-4.30 a share with a total of >11,000 shares. Just waiting for a sell point.